JEFFREY COHEN
Profile
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
EXECUTIVE OFFICER, DIRECTOR
DIRECTOR
EXECUTIVE OFFICER
BRIAN ANCELL, JOHN DIBIASI, BOB FABBIO, LINDA FENTON, BRUCE HALLETT, JASON KELLER, NINA KJELLSON, STEPHEN KRAUS, MOHAMAD MAKHZOUMI, JEFFREY MARGOLIS, JEFFREY H MARGOLIS, JEFFREY H. MARGOLIS, KHALED NASR, REGINA PAOLILLO, CHRIS POWER, SCOTT ROTERMUND, ROB SCAVO, DAN SIMON, DANIEL SIMON, KEVIN SPAIN, SHARON STEVENSON, JAMES SULLIVAN, JAMES J. SULLIVAN, PHILIP TAMMINGA
DIRECTOR
EXECUTIVE OFFICER, DIRECTOR
EXECUTIVE OFFICER
DIRECTOR
DIRECTOR
EXECUTIVE OFFICER
EXECUTIVE OFFICER
EXECUTIVE OFFICER, DIRECTOR
DIRECTOR
ELLEN BEAUSANG, ROBERT BEECHEY, JODY BERRY, MICHAEL BUHLE, JAMES BURNS, JAMES S. BURNS, STEFANIE CAVANAUGH, NANCY G. COCOZZA, JAMES CRAWFORD, WILLIAM CREECH, CELESTE FRALICK, JACK FRASER, JOHN FRASER, ROBERT GOGGIN, JOHN F. HAMILTON, JANNIE HERCHUK, TORSTEN HOMBECK, BRUCE HUEBNER, CYNTHIA HUNDORFEAN, BRIAN HUNGERFORD, VERONICA G. H. JORDAN, JAMES T. LAFRANCE, THOMAS MCLAIN, MINH MERCHANT, DONALD MUNROE, LYNN O-CONNOR VOS, ELLEN O-CONNOR-VOS, GAIL S. PAGE, VALERIE B. PALMIERI, WINFRED PARNELL, JOHN RAGARD, PETER RODDY, NICOLE SANDFORD, ERIC SCHOEN, DAVID R. SCHREIBER, CARL SEVERINGHAUS, JOHN STRAHLEY, WILLIAM WALLEN, JANE PINE WOOD
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity
2026-06-05
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity
2025-09-16
D
COMMERCIAL BANKING
NATIONAL COMMERCIAL BANKS [6021]
DECLINE TO DISCLOSE
Equity
2012-09-28

